[PDF][PDF] Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine
…, LS Reyes, A Linder, G Sandhar, JA Kilby, JK Tyerman… - Cell, 2021 - cell.com
Extension of the interval between vaccine doses for the BNT162b2 mRNA vaccine was
introduced in the United Kingdom to accelerate population coverage with a single dose. At this …
introduced in the United Kingdom to accelerate population coverage with a single dose. At this …
[HTML][HTML] T-cell and antibody responses to first BNT162b2 vaccine dose in previously infected and SARS-CoV-2-naive UK health-care workers: a multicentre …
…, J Tyerman, J Kilby, J Cutteridge, K Lillie… - The Lancet …, 2022 - thelancet.com
Background Previous infection with SARS-CoV-2 affects the immune response to the first
dose of the SARS-CoV-2 vaccine. We aimed to compare SARS-CoV-2-specific T-cell and …
dose of the SARS-CoV-2 vaccine. We aimed to compare SARS-CoV-2-specific T-cell and …
[HTML][HTML] Omicron infection following vaccination enhances a broad spectrum of immune responses dependent on infection history
Pronounced immune escape by the SARS-CoV-2 Omicron variant has resulted in many
individuals possessing hybrid immunity, generated through a combination of vaccination and …
individuals possessing hybrid immunity, generated through a combination of vaccination and …
T-cell and antibody responses to first BNT162b2 vaccine dose in previously SARS-CoV-2-infected and infection-naive UK healthcare workers: a multicentre …
…, A Cross, G Sandhar, JA Kilby, JK Tyerman… - 2021 - papers.ssrn.com
Background: Following a single dose of BNT162b2 mRNA vaccine, higher antibody titres
are observed following prior SARS-CoV-2 infection than in infection-naive individuals, but T-…
are observed following prior SARS-CoV-2 infection than in infection-naive individuals, but T-…
[PDF][PDF] Evolution of long-term vaccine-induced and hybrid immunity in healthcare workers after different COVID-19 vaccine regimens
…, P Supasa, A Tuekprakhon, A Cross, JK Tyerman… - Med, 2023 - cell.com
Background Both infection and vaccination, alone or in combination, generate antibody and
T cell responses against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). …
T cell responses against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). …
Sustained T cell immunity, protection and boosting using extended dosing intervals of BNT162b2 mRNA vaccine
…, P Supasa, A Cross, G Sandhar, JA Kilby, JK Tyerman… - 2021 - papers.ssrn.com
Extension of the interval between vaccine doses for the BNT162b2 mRNA vaccine was
introduced in the UK to accelerate population coverage with a single dose. In a study of 503 …
introduced in the UK to accelerate population coverage with a single dose. In a study of 503 …
Evolution of long-term hybrid immunity in healthcare workers after different COVID-19 vaccination regimens: a longitudinal observational cohort study
…, P Supasa, A Tuekprakhon, A Cross, JK Tyerman… - MedRxiv, 2022 - medrxiv.org
Both infection and vaccination, alone or in combination, generate antibody and T cell
responses against SARS-CoV-2. However, the maintenance of such responses – and hence …
responses against SARS-CoV-2. However, the maintenance of such responses – and hence …
Omicron BA. 1/BA. 2 infections in triple-vaccinated individuals enhance a diverse repertoire of mucosal and blood immune responses
Pronounced immune escape by the SARS-CoV-2 Omicron variant has resulted in large
numbers of individuals with hybrid immunity, generated through a combination of vaccination …
numbers of individuals with hybrid immunity, generated through a combination of vaccination …
896 Use of renal biopsy in the diagnosis and management of paediatric lupus nephritis with outcome analysis in UK tertiary centre
T Reilly, J Hardwick, J Presky, K Tyerman, T Amin - 2023 - adc.bmj.com
Objectives Lupus Nephritis (LN) occurs in 50–60% of children with Systemic Lupus Erythematous
1 and it is often evident at presentation, with accrued parenchymal damage. European …
1 and it is often evident at presentation, with accrued parenchymal damage. European …
[HTML][HTML] Aminoaciduria in the prediction of ifosfamide-induced tubulopathy after childhood cancer: a feasibility study
JE Morgan, K McKeever, KS Tyerman… - Pilot and Feasibility …, 2016 - Springer
Background Ifosfamide, an alkylating agent used widely in the treatment of childhood
malignancy, can cause many side effects including a proximal tubulopathy. Studies suggest that …
malignancy, can cause many side effects including a proximal tubulopathy. Studies suggest that …
